Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30–October 1, 2015

Vaccine

Volumn 35, Issue 18, 2017, Pages 2279-2287

  Fell, Deshayne B ^a,b   Bhutta, Zulfiqar A ^c   Hutcheon, Jennifer A ^d   Karron, Ruth A ^e   Knight, Marian ^f   Kramer, Michael S ^g   Monto, Arnold S ^h   Swamy, Geeta K ⁱ   Ortiz, Justin R ^j   Savitz, David A ^k  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k BROWN UNIVERSITY   (United States)

more..

Author keywords

Fetal growth; Influenza vaccination; Pregnancy; Preterm birth; Stillbirth

Indexed keywords

INFLUENZA VACCINE;

ADVERSE OUTCOME; BANGLADESH; CANADA; CONFERENCE PAPER; CONSULTATION; DISEASE SEVERITY; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS RISK; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INTRAUTERINE INFECTION; MATERNAL DISEASE; OBSERVATIONAL STUDY; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOUTH AFRICA; WORLD HEALTH ORGANIZATION; FETOMATERNAL TRANSFUSION; MATERNAL EXPOSURE; PATHOLOGY; PREGNANCY COMPLICATION;

FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 85016880810     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.03.056     Document Type: Conference Paper

References (100)

1. [1] Kay, A.W., Blish, C.A., Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Front Immunol, 6, 2015, 289.
2. [2] Zaman, K., Roy, E., Arifeen, S.E., Rahman, M., Raqib, R., Wilson, E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 (2008), 1555–1564.
3. [3] Madhi, S.A., Cutland, C.L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., et al. Influenza vaccination of pregnant women and protection of their Infants. N Engl J Med 371 (2014), 918–931.
4. [4] Savitz, D.A., Fell, D.B., Ortiz, J.R., Bhat, N., Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine 33 (2015), 6430–6435.
5. [5] Steinhoff, M.C., MacDonald, N., Pfeifer, D., Muglia, L.J., Influenza vaccine in pregnancy: policy and research strategies. Lancet 383 (2014), 1611–1613.
6. [6] Ortiz, J.R., Englund, J.A., Neuzil, K.M., Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 29 (2011), 4439–4452.
7. [7] Fell, D.B., Platt, R.W., Lanes, A., Wilson, K., Kaufman, J.S., Basso, O., et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 122 (2015), 17–26.
8. [8] Bratton, K.N., Wardle, M.T., Orenstein, W.A., Omer, S.B., Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis 60 (2015), e11–e19.
9. [9] Global Alliance for Vaccines and Immunisation (GAVI). Final vaccine investment strategy analysis 2013: maternal influenza; 2013. p. 12. http://www.gavi.org/about/strategy/vaccine-investment-strategy/.
10. [10] Omer, S.B., Goodman, D., Steinhoff, M.C., Rochat, R., Klugman, K.P., Stoll, B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med, 8, 2011, e1000441.
11. [11] Lambach, P., Hombach, J., Ortiz, J.R., A global perspective of maternal influenza immunization. Vaccine, 2015, 8–11.
12. [12] Blencowe, H., Cousens, S., Oestergaard, M.Z., Chou, D., Moller, A.-B., Narwal, R., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379 (2012), 2162–2172.
13. [13] Varner, M.W., Esplin, M.S., Current understanding of genetic factors in preterm birth. BJOG 112:Suppl. (2005), 28–31.
14. [14] Goldenberg, R.L., Culhane, J.F., Iams, J.D., Romero, R., Epidemiology and causes of preterm birth. Lancet 371 (2008), 75–84.
15. [15] Kramer, M.S., Intrauterine growth and gestational duration determinants. Pediatrics 80 (1987), 502–511.
16. [16] Villar, J., Cheikh Ismail, L., Victora, C.G., Ohuma, E.O., Bertino, E., Altman, D.G., et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21 st Project. Lancet 384 (2014), 857–868.
17. [17] Lee, A.C.C., Katz, J., Blencowe, H., Cousens, S., Kozuki, N., Vogel, J.P., et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Global Health 1 (2013), e26–e36.
18. [18] Wilcox, A.J., On the importance–and the unimportance– of birthweight. Int J Epidemiol 30 (2001), 1233–1241.
19. [19] Joseph, K.S., Kinniburgh, B., Hutcheon, J.A., Mehrabadi, A., Dahlgren, L., Basso, M., et al. Rationalizing definitions and procedures for optimizing clinical care and public health in fetal death and stillbirth. Obstet Gynecol 125 (2015), 784–788.
20. [20] Gravett, M.G., Rubens, C.E., Nunes, T.M., Global report on preterm birth and stillbirth (2 of 7): discovery science. BMC Pregnancy Childbirth, 10(Suppl. 1), 2010, S2.
21. [21] Lawn, J.E., Yakoob, M.Y., Haws, R.A., Soomro, T., Darmstadt, G.L., Bhutta, Z.A., 3.2 Million stillbirths: epidemiology and overview of the evidence review. BMC Pregnancy Childbirth, 9(Suppl. 1), 2009, S2.
22. [22] Lawn, J.E., Blencowe, H., Waiswa, P., Amouzou, A., Mathers, C., Hogan, D., et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet 387 (2016), 587–603.
23. [23] Stillbirth Collaborative Research Network Writing Group, Association between stillbirth and risk factors known at pregnancy confirmation. JAMA 306 (2011), 2469–2479.
24. [24] Bukowski, R., Carpenter, M., Conway, D., Coustan, D., Dudley, D.J., Goldenberg, R.L., et al. Causes of death among stillbirths. JAMA 306 (2011), 2459–2468.
25. [25] Cousens, S., Blencowe, H., Stanton, C., Chou, D., Ahmed, S., Steinhardt, L., et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet 377 (2011), 1319–1330.
26. [26] Cunningham, F., (eds.) Maternal physiology. Williams obstet, 23rd ed., 2010, McGraw-Hill Medical, New York.
27. [27] Pazos, M., Sperling, R.S., Moran, T.M., Kraus, T.A., The influence of pregnancy on systemic immunity. Immunol Res 54 (2012), 254–261.
28. [28] Jamieson, D.J., Theiler, R.N., Rasmussen, S.A., Emerging infections and pregnancy. Emerg Infect Dis 12 (2006), 1638–1643.
29. [29] Kourtis, A.P., Read, J.S., Jamieson, D.J., Pregnancy and infection. N Engl J Med 370 (2014), 2211–2218.
30. [30] Kay, A.W., Fukuyama, J., Aziz, N., Dekker, C.L., Mackey, S., Swan, G.E., et al. Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy. Proc Natl Acad Sci 111 (2014), 14506–14511.
31. [31] Siston, A.M., Rasmussen, S.A., Honein, M.A., Fry, A.M., Seib, K., Callaghan, W.M., et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 303 (2010), 1517–1525.
32. [32] Harris, J., Influenza occurring in pregnant women. J Am Med Assoc 72 (1919), 978–980.
33. [33] Freeman, D.W., Barno, A., Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 78 (1959), 1172–1175.
34. [34] Mosby, L.G., Rasmussen, S.A., Jamieson, D.J., 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 205 (2011), 10–18.
35. [35] Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)—United States, April 2009–August 2010. MMWR Morb Mortal Wkly Rep 2011;60:1193–6.
36. [36] Mertz, D., Geraci, J., Winkup, J., Gessner, B.D., Ortiz, J.R., Loeb, M., Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine 35 (2016), 521–528.
37. [37] World Health Organization. WHO taskforce to evaluate influenza data to inform vaccine impact and economic modelling; 2014. http://www.who.int/immunization/research/meetings_workshops/taskforceinterimreportMarch2015/en/.
38. [38] Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64 (2011), 383–394.
39. [39] Hardy, J.M., Azarowicz, E.N., Mannini, A., Medearis, D.N., Cooke, R.E., The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957–1958. Am J Public Health Nations Health 51 (1961), 1182–1188.
40. [40] Widelock, D., Csizmas, L., Klein, S., Influenza, pregnancy, and fetal outcome. Public Health Rep 78 (1963), 1–11.
41. [41] Gérardin, P., El Amrani, R., Cyrille, B., Gabrièle, M., Guillermin, P., Boukerrou, M., et al. Low clinical burden of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La Réunion. PLoS ONE, 5, 2010, e10896.
42. [42] Malinowski, A.K., McGeer, A., Robertson, J., Sermer, M., Farine, D., Lapinsky, S.E., et al. H1N1 in pregnancy: a tertiary care centre experience. J Obstet Gynaecol Can 33 (2011), 698–704.
43. [43] Liu, S.-L., Wang, J., Yang, X.-H., Chen, J., Huang, R.-J., Ruan, B., et al. Pandemic influenza A(H1N1) 2009 virus in pregnancy. Rev Med Virol 23 (2013), 3–14.
44. [44] Bhalerao-Gandhi, A., Chhabra, P., Arya, S., Simmerman, J.M., Influenza and pregnancy: a review of the literature from India. Infect Dis Obstet Gynecol, 2015, 2015, 867587.
45. [45] Meijer, W.J., van Noortwijk, A.G., Bruinse, H.W., Wensing, A.M., Influenza virus infection in pregnancy: a review. Acta Obstet Gynecol Scand 94 (2015), 797–819.
46. [46] Moro, P.L., Broder, K., Zheteyeva, Y., Revzina, N., Tepper, N., Kissin, D., et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 205:473 (2011), e1–e9.
47. [47] Fell, D.B., Savitz, D.A., Kramer, M.S., Gessner, B.D., Katz, M.A., Knight, M., et al. Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG 124 (2017), 48–59.
48. [48] Pierce, M., Kurinczuk, J.J., Spark, P., Brocklehurst, P., Knight, M., Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ, 342, 2011, d3214.
49. [49] Doyle, T.J., Goodin, K., Hamilton, J.J., Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza A(H1N1) illness in Florida, 2009–2010: a population-based cohort study. PLoS ONE, 8, 2013, e79040.
50. [50] Håberg, S.E., Trogstad, L., Gunnes, N., Wilcox, A.J., Gjessing, H.K., Samuelsen, S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 368 (2013), 333–340.
51. [51] Hansen, C., Desai, S., Bredfeldt, C., Cheetham, C., Gallagher, M., Li, D.-K., et al. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis 206 (2012), 1260–1268.
52. [52] Naresh, A., Fisher, B.M., Hoppe, K.K., Catov, J., Xu, J., Hart, J., et al. A multicenter cohort study of pregnancy outcomes among women with laboratory-confirmed H1N1 influenza. J Perinatol 33 (2013), 939–943.
53. [53] McNeil, S.A., Dodds, L.A., Fell, D.B., Allen, V.M., Halperin, B.A., Steinhoff, M.C., et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol 204 (2011), S54–S57.
54. [54] Martin, A., Cox, S., Jamieson, D.J., Whiteman, M.K., Kulkarni, A., Tepper, N.K., Respiratory illness hospitalizations among pregnant women during influenza season, 1998–2008. Matern Child Health J 17 (2013), 1325–1331.
55. [55] Uchide, N., Ohyama, K., Bessho, T., Takeichi, M., Toyoda, H., Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection. Mediators Inflamm, 2012, 10.1155/2012/270670 270670.
56. [56] Lieberman, R.W., Bagdasarian, N., Thomas, D., Van De Ven, C., Seasonal influenza A (H1N1) infection in early pregnancy and second trimester fetal demise. Emerg Infect Dis 17 (2011), 107–109.
57. [57] Yawn, D.H., Pyeatte, J.C., Joseph, J.M., Eichler, S.L., Garcia-Bunuel, R., Transplacental transfer of influenza virus. JAMA 216 (1971), 1022–1023.
58. [58] McGregor, J.A., Burns, J.C., Levin, M.J., Burlington, B., Meiklejohn, G., Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am J Obstet Gynecol 149 (1984), 856–859.
59. [59] Trinh, Q.D., Izumi, Y., Komine-Aizawa, S., Shibata, T., Shimotai, Y., Kuroda, K., et al. H3N2 influenza A virus replicates in immortalized human first trimester trophoblast cell lines and induces their rapid apoptosis. Am J Reprod Immunol 62 (2009), 139–146.
60. [60] Steinhoff, M.C., MacDonald, N.E., Influenza pandemics–pregnancy, pathogenesis, and perinatal outcomes. JAMA 308 (2012), 184–185.
61. [61] Irving, W.L., James, D.K., Stephenson, T., Laing, P., Jameson, C., Oxford, J.S., et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 107 (2000), 1282–1289.
62. [62] Bradley-Stewart, A., Jolly, L., Adamson, W., Gunson, R., Frew-Gillespie, C., Templeton, K., et al. Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09. J Clin Virol 58 (2013), 100–107.
63. [63] Muglia, L.J., Katz, M., The enigma of spontaneous preterm birth. N Engl J Med 362 (2010), 529–535.
64. [64] Steinhoff, M.C., Omer, S.B., A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol 207 (2012), S21–S27.
65. [65] Kwit, K., Pomorska-Mól, M., Markowska-Daniel, I., Pregnancy outcome and clinical status of gilts following experimental infection by H1N2, H3N2 and H1N1pdm09 influenza A viruses during the last month of gestation. Adv Virol 160 (2015), 2415–2425.
66. [66] Edwards, M.J., Review: hyperthermia and fever during pregnancy. Birth Defects Res A Clin Mol Teratol 76 (2006), 507–516.
67. [67] Moretti, M.E., Bar-Oz, B., Fried, S., Koren, G., Maternal hyperthermia and the risk for neural tube defects in offspring. Epidemiology 16 (2005), 216–219.
68. [68] Rasmussen, S.A., Hayes, E.B., Jamieson, D.J., O'Leary, D.R., Emerging infections and pregnancy: assessing the impact on the embryo or fetus. Am J Med Genet A 143A (2007), 2896–2903.
69. [69] Dodds, L., McNeil, S.A., Fell, D.B., Allen, V.M., Coombs, A., Scott, J., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 176 (2007), 463–468.
70. [70] Neuzil, K.M., Reed, G.W., Mitchel, E.F., Simonsen, L., Griffin, M.R., Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 148 (1998), 1094–1102.
71. [71] Pasternak, B., Svanström, H., Mølgaard-Nielsen, D., Krause, T.G., Emborg, H.-D., Melbye, M., et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ, 344, 2012, e2794.
72. [72] Fell, D.B., Sprague, A.E., Liu, N., Yasseen, A.S., Wen, S.-W., Smith, G., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 102 (2012), e33–e40.
73. [73] Källén, B., Olausson, P.O., Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study. BJOG 119 (2012), 1583–1590.
74. [74] Legge, A., Dodds, L., Macdonald, N.E., Scott, J., McNeil, S., Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ 186 (2014), E157–E164.
75. [75] Richards, J.L., Hansen, C., Bredfeldt, C., Bednarczyk, R.A., Steinhoff, M.C., Adjaye-Gbewonyo, D., et al. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis 56 (2013), 1216–1222.
76. [76] Rubinstein, F., Micone, P., Bonotti, A., Wainer, V., Schwarcz, A., Augustovski, F., et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ, 346, 2013, f393.
77. [77] Hutcheon, J.A., Fell, D.B., Jackson, M.L., Kramer, M.S., Ortiz, J.R., Savitz, D.A., et al. Detectable risks in studies of the fetal benefits of maternal influenza vaccination. Am J Epidemiol 184 (2016), 227–232.
78. [78] Hutcheon, J.A., Savitz, D.A., Invited commentary: influenza, influenza immunization, and pregnancy - it's about time. Am J Epidemiol 184 (2016), 187–191.
79. [79] Nelson, J.C., Jackson, M.L., Weiss, N.S., Jackson, L.A., New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 62 (2009), 687–694.
80. [80] Simonsen, L., Viboud, C., Taylor, R.J., Miller, M.A., Jackson, L., Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 27 (2009), 6300–6304.
81. [81] Campitelli, M.A., Rosella, L.C., Stukel, T.A., Kwong, J.C., Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine 29 (2010), 240–246.
82. [82] Hottes, T.S., Skowronski, D.M., Hiebert, B., Janjua, N.Z., Roos, L.L., Van Caeseele, P., et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS ONE, 6, 2011, e22618.
83. [83] Jackson, L.A., Jackson, M.L., Nelson, J.C., Neuzil, K.M., Weiss, N.S., Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35 (2006), 337–344.
84. [84] Sammon, C.J., Snowball, J., McGrogan, A., de Vries, C.S., Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD. PLoS ONE, 7, 2012, e51734.
85. [85] World Health Organization, Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec 47 (2012), 461–476.
86. [86] Osterholm, M.T., Kelley, N.S., Sommer, A., Belongia, E.A., Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12 (2012), 36–44.
87. [87] Omer, S.B., Richards, J.L., Madhi, S.A., Tapia, M.D., Steinhoff, M.C., Aqil, A.R., et al. Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: methods and expectations. Vaccine 33 (2015), 3801–3812.
88. [88] Steinhoff, M.C., Omer, S.B., Roy, E., El Arifeen, S., Raqib, R., Dodd, C., et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 184 (2012), 645–653.
89. [89] Simões, E.A.F., Cutland, C., Carosone-Link, P., Hugo, A., Jones, S., Madimabe, R., et al. Lack of efficacy of trivalent influenza vaccination of HIV negative pregnant women against adverse fetal outcomes: a randomized clinical trial. 2015, IDSA, San Diego (CA).
90. [90] Kramer, M.S., Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 65 (1987), 663–737.
91. [91] Lipsitch, M., Tchetgen Tchetgen, E., Cohen, T., Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 21 (2010), 383–388.
92. [92] Tapia, M.D., Sow, S.O., Tamboura, B., Tégueté, I., Pasetti, M.F., Kodio, M., et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis, 2016 3099.
93. [93] Nordin, J.D., Kharbanda, E.O., Vazquez Benitez, G., Lipkind, H., Vellozzi, C., Destefano, F., Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 164 (2014), 1051–1057.
94. [94] Baum, U., Leino, T., Gissler, M., Kilpi, T., Jokinen, J., Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: a cohort study of pregnancies stratified by trimester of vaccination. Vaccine 33 (2015), 4850–4857.
95. [95] Fabiani, M., Bella, A., Rota, M.C., Clagnan, E., Gallo, T., D'Amato, M., et al. A/H1N1 pandemic influenza vaccination: a retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy. Vaccine 33 (2015), 2240–2247.
96. [96] Ahrens, K.A., Louik, C., Kerr, S., Mitchell, A.A., Werler, M.M., Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth. Paediatr Perinat Epidemiol 28 (2014), 498–509.
97. [97] Trotta, F., Da Cas, R., Spil-Alegiani, S., Gramegna, M., Venegoni, M., Zocchetti, C.T.G., A cohort study to evaluate the safety of A/H1N1 pandemic vaccine during pregnancy. BMJ, 348, 2014, g3361.
98. [98] Olsen, S.J., Mirza, S.A., Vonglokham, P., Khanthamaly, V., Chitry, B., Pholsena, V., et al. The effect of influenza vaccination on birth outcomes in a cohort of pregnant women in Lao PDR, 2014–2015. Clin Infect Dis 63 (2016), 487–494.
99. [99] Ludvigsson, J.F., Ström, P., Lundholm, C., Cnattingius, S., Ekbom, A., Örtqvist, Å., et al. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ, 351, 2015, h5585.
100. [100] Regan, A.K., Moore, H.C., de Klerk, N., Omer, S.B., Shellam, G., Mak, D.B., et al. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin Infect Dis 62 (2016), 1221–1227.